基岩
抗药性
医学
重症监护医学
药品
广泛耐药结核
药物耐受性
肺结核
病毒学
多重耐药
微生物学
药理学
结核分枝杆菌
生物
病理
作者
James Millard,Stephanie Rimmer,Camus Nimmo,Max O’Donnell
标识
DOI:10.3201/eid2905.221716
摘要
New classes of antitubercular drugs, diarylquinolines and nitroimidazoles, have been associated with improved outcomes in the treatment of drug-resistant tuberculosis, but that success is threatened by emerging drug resistance. We report a case of bedaquiline and delamanid resistance in a 55-year-old woman in South Africa with extensively drug-resistant tuberculosis and known HIV.
科研通智能强力驱动
Strongly Powered by AbleSci AI